Literature DB >> 7358748

The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses.

H J Mankin, K P Cantley, L Lippiello, A L Schiller, C J Campbell.   

Abstract

Tissues from sixty-nine cartilage tumors in sixty-six individuals were obtained at the time of operation and each lesion was graded as benign (seventeen) or as a low-grade (thirty-three) or high-grade (nineteen) chondrosarcoma according to histological and roentgenographic criteria. The material obtained was analyzed by biochemical techniques for its content of water, ash, DNA, total protein (composed of collagen and so-called excess protein), and carbohydrate. In addition, proteoglycan subunit was isolated and the chain lengths of chrondroitin sulphate and keratan sulphate were determined. Analysis of the data showed that for the most part the tumors differed only quantitatively from articular cartilage controls, with the principal variations noted in water, ash, protein, and collagen content. Sugar concentrations were highly variable, but analysis of the proteoglycan subunit showed a distribution of glycosaminoglycans characteristic of immature articular cartilage. Marked shortening of the keratan sulphate chains was noted without significant alteration in the chain lengths of chondroitin sulphate, The wide variations in pattern suggest that the cartilage tumors are not biochemically homogeneous and therefore probably do not represent a single group of genetic errors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358748

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  15 in total

1.  New cell lines with chondrocytic phenotypes from human chondrosarcoma.

Authors:  Ikuo Kudawara; Nobuhito Araki; Akira Myoui; Yoichi Kato; Atsumasa Uchida; Hideki Yoshikawa
Journal:  Virchows Arch       Date:  2004-04-29       Impact factor: 4.064

2.  Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.

Authors:  T Aigner; S Dertinger; S I Vornehm; J Dudhia; K von der Mark; T Kirchner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Tumors of the musculoskeletal system: magnetic resonance imaging and computed tomography.

Authors:  D I Rosenthal
Journal:  Bull N Y Acad Med       Date:  1987-06

4.  Chondromyxosarcoma: a rare form of bone neoplasm in children.

Authors:  J P Laissy; F Guillon; A M Chesneau; E Schouman-Claeys; M Blery
Journal:  Pediatr Radiol       Date:  1987

5.  Synthesis of pro-collagen type II by a xenotransplanted human chondroblastic osteosarcoma.

Authors:  W L Lanzer; L A Liotta; C Yee; H A Azar; J Costa
Journal:  Am J Pathol       Date:  1981-09       Impact factor: 4.307

6.  Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone.

Authors:  Y Ueda; Y Oda; H Tsuchiya; K Tomita; I Nakanishi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

7.  A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.

Authors:  Heike Welkerling; Susanne Kratz; Volker Ewerbeck; Günter Delling
Journal:  Virchows Arch       Date:  2003-09-25       Impact factor: 4.064

8.  Borderline chondrosarcoma of long and flat bones.

Authors:  H Tsuchiya; Y Ueda; H Morishita; A Nonomura; A Kawashima; E J Fellinger; K Tomita
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Expression of CD44 in human neoplastic and normal hyaline cartilage.

Authors:  Patrick P Bosch; Jeff W Stevens; Kenneth J Noonan; Joseph A Buckwalter; Ronald J Midura
Journal:  Iowa Orthop J       Date:  2002

10.  Differentiating high-grade from low-grade chondrosarcoma with MR imaging.

Authors:  Hye Jin Yoo; Sung Hwan Hong; Ja-Young Choi; Kyung Chul Moon; Han-Soo Kim; Jung-Ah Choi; Heung Sik Kang
Journal:  Eur Radiol       Date:  2009-12       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.